Lv1
60 积分 2024-11-21 加入
Clinical Pharmacokinetics and Pharmacodynamics of Selumetinib
1天前
待确认
A Phase 2 PBTC Study of Selumetinib for Recurrent/Progressive Pediatric Low-Grade Glioma: Strata 2, 5, and 6 with Long-term Outcomes on Strata 1, 3, and 4
10天前
已完结
Predicting neurofibromatosis type 1 risk among children with isolated café-au-lait macules
1个月前
已完结
Height Growth Impairment in Children With Neurofibromatosis Type 1 Is Characterized by Decreased Pubertal Growth Velocity in Both Sexes
2个月前
已完结
Growth, Puberty, and Endocrine Functions in Patients With Sporadic or Familial Neurofibromatosis Type 1: A Longitudinal Study
2个月前
已完结
Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1 With MEK Inhibitor Selumetinib
2个月前
已完结
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas
3个月前
已完结
Adeno-associated viral vector targeted evolution for neurofibromatosis gene delivery
3个月前
已完结
Precocious Puberty in Children with Neurofibromatosis Type 1
4个月前
已完结
Patient characteristics, treatment patterns, healthcare resource utilization, and costs among patients diagnosed with neurofibromatosis type 1 with and without plexiform neurofibromas in Japan
6个月前
已完结
皖公网安备34019202002308
